Dietary Supplement
Oligopin
Oligopin is a dietary supplement with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
80%
Ph phase_3
1
20%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
4(80.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (20.0%)
N/A4 (80.0%)
Trials by Status
completed480%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Effect of Oligopin® on Skin Ageing
NCT04141059
completednot_applicable
Effect of Oligopin® on Blood Pressure.
NCT02063477
unknownnot_applicable
A Study to Determine the Safety and Efficacy of Oligopin® on Metabolic Risk Factors in Subjects With Metabolic Syndrome
NCT04488653
completedphase_3
Oligopin Supplementation and Bone Turnover Markers and Antioxidant Changes in Postmenopausal Osteopenic Women
NCT03260803
completednot_applicable
Therapeutic Effects of Pine Bark Extracts in Attention Deficit Hyperactivity Disorder
NCT03368690
Clinical Trials (5)
Showing 5 of 5 trials
NCT04141059Not Applicable
Effect of Oligopin® on Skin Ageing
NCT02063477Not Applicable
Effect of Oligopin® on Blood Pressure.
NCT04488653Not Applicable
A Study to Determine the Safety and Efficacy of Oligopin® on Metabolic Risk Factors in Subjects With Metabolic Syndrome
NCT03260803Phase 3
Oligopin Supplementation and Bone Turnover Markers and Antioxidant Changes in Postmenopausal Osteopenic Women
NCT03368690Not Applicable
Therapeutic Effects of Pine Bark Extracts in Attention Deficit Hyperactivity Disorder
All 5 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 5